Shanghai Junshi Biosciences Statistics

Total Valuation

Shanghai Junshi Biosciences has a market cap or net worth of HKD 27.93 billion. The enterprise value is 27.75 billion.

Market Cap	27.93B
Enterprise Value	27.75B

Important Dates

The last earnings date was Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Shanghai Junshi Biosciences has 984.87 million shares outstanding. The number of shares has increased by 1.33% in one year.

Current Share Class	n/a
Shares Outstanding	984.87M
Shares Change (YoY)	+1.33%
Shares Change (QoQ)	-3.49%
Owned by Insiders (%)	19.99%
Owned by Institutions (%)	17.67%
Float	571.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.46
PB Ratio	0.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.89
EV / Sales	14.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.88

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.44.

Current Ratio	2.00
Quick Ratio	1.62
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-1.21
Interest Coverage	-45.05

Financial Efficiency

Return on equity (ROE) is -26.94% and return on invested capital (ROIC) is -12.49%.

Return on Equity (ROE)	-26.94%
Return on Assets (ROA)	-10.52%
Return on Capital (ROIC)	-12.49%
Revenue Per Employee	770,893
Profits Per Employee	-777,833
Employee Count	2,568
Asset Turnover	0.16
Inventory Turnover	0.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.67% in the last 52 weeks. The beta is 0.35, so Shanghai Junshi Biosciences's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-40.67%
50-Day Moving Average	13.41
200-Day Moving Average	12.11
Relative Strength Index (RSI)	46.38
Average Volume (20 Days)	1,961,401

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Junshi Biosciences had revenue of HKD 1.98 billion and -2.00 billion in losses. Loss per share was -2.03.

Revenue	1.98B
Gross Profit	1.29B
Operating Income	-2.09B
Pretax Income	-2.07B
Net Income	-2.00B
EBITDA	-1.78B
EBIT	-2.09B
Loss Per Share	-2.03

Full Income Statement

Balance Sheet

The company has 3.37 billion in cash and 3.07 billion in debt, giving a net cash position of 297.54 million or 0.30 per share.

Cash & Cash Equivalents	3.37B
Total Debt	3.07B
Net Cash	297.54M
Net Cash Per Share	0.30
Equity (Book Value)	6.96B
Book Value Per Share	31.18
Working Capital	2.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.61 billion and capital expenditures -940.01 million, giving a free cash flow of -2.55 billion.

Operating Cash Flow	-1.61B
Capital Expenditures	-940.01M
Free Cash Flow	-2.55B
FCF Per Share	-2.59

Full Cash Flow Statement

Margins

Gross margin is 65.15%, with operating and profit margins of -105.71% and -100.90%.

Gross Margin	65.15%
Operating Margin	-105.71%
Pretax Margin	-104.56%
Profit Margin	-100.90%
EBITDA Margin	-90.05%
EBIT Margin	-105.71%
FCF Margin	-128.85%

Dividends & Yields

Shanghai Junshi Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.33%
Shareholder Yield	-1.33%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai Junshi Biosciences has an Altman Z-Score of 2.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	n/a